$YTENQ
YIELD10 BIOSCIENCE, INC.

2017 Q3 Form 10-Q Financial Statement

#000112170217000084 Filed on November 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q4 2016 Q3
Revenue $223.0K $340.0K $473.0K
YoY Change -52.85% -31.45% 44.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.073M $790.0K $1.530M
YoY Change -29.87% -51.83% -13.51%
% of Gross Profit
Research & Development $1.130M $1.150M $1.550M
YoY Change -27.1% -26.75% -6.63%
% of Gross Profit
Depreciation & Amortization $50.00K $60.00K $190.0K
YoY Change -73.68% -40.0% 171.43%
% of Gross Profit
Operating Expenses $1.073M $1.930M $1.530M
YoY Change -29.87% -39.69% -13.51%
Operating Profit -$1.982M -$2.604M
YoY Change -23.89% -16.16%
Interest Expense -$40.00K -$10.00K $2.000K
YoY Change -2100.0% 100.0%
% of Operating Profit
Other Income/Expense, Net -$43.00K -$30.00K -$8.000K
YoY Change 437.5% 50.0% -900.0%
Pretax Income -$2.025M -$1.630M -$2.612M
YoY Change -22.47% -47.76% -15.88%
Income Tax $0.00 -$60.00K -$1.042M
% Of Pretax Income
Net Earnings -$2.030M -$1.930M $4.020M
YoY Change -150.5% -67.38% -168.74%
Net Earnings / Revenue -910.31% -567.65% 849.89%
Basic Earnings Per Share
Diluted Earnings Per Share -$22.56M -$27.57M $57.43M
COMMON SHARES
Basic Shares Outstanding 2.880M shares 28.34M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2016 Q4 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.000M $7.300M $9.800M
YoY Change -69.39% -40.65% -45.25%
Cash & Equivalents $2.951M $7.309M $9.782M
Short-Term Investments
Other Short-Term Assets $300.0K $400.0K $300.0K
YoY Change 0.0% -81.82% -78.57%
Inventory $0.00 $0.00
Prepaid Expenses
Receivables $135.0K $66.00K $198.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.484M $7.860M $10.58M
YoY Change -67.07% -47.07% -48.2%
LONG-TERM ASSETS
Property, Plant & Equipment $1.587M $1.739M $1.796M
YoY Change -11.64% 1556.19% 97.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $69.00K $95.00K $717.0K
YoY Change -90.38% 0.0% 321.76%
Total Long-Term Assets $2.088M $2.888M $2.945M
YoY Change -29.1% 29.04% 73.54%
TOTAL ASSETS
Total Short-Term Assets $3.484M $7.860M $10.58M
Total Long-Term Assets $2.088M $2.888M $2.945M
Total Assets $5.572M $10.75M $13.53M
YoY Change -58.8% -37.1% -38.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.00K $56.00K $229.0K
YoY Change -79.04% -53.33% -48.88%
Accrued Expenses $1.938M $2.702M $2.749M
YoY Change -29.5% -23.09% -23.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.986M $2.758M $2.978M
YoY Change -33.31% -29.46% -28.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.000M $0.00 $1.969M
YoY Change -49.21% -100.0% 1212.67%
Total Long-Term Liabilities $1.000M $0.00 $1.969M
YoY Change -49.21% -100.0% 1212.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.986M $2.758M $2.978M
Total Long-Term Liabilities $1.000M $0.00 $1.969M
Total Liabilities $3.023M $4.379M $4.947M
YoY Change -38.89% 7.86% 13.93%
SHAREHOLDERS EQUITY
Retained Earnings -$340.2M -$333.4M -$331.4M
YoY Change 2.65% 2.33% 3.62%
Common Stock $342.8M $339.8M $340.1M
YoY Change 0.81% 0.28% 0.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.549M $6.369M $8.578M
YoY Change
Total Liabilities & Shareholders Equity $5.572M $10.75M $13.53M
YoY Change -58.8% -37.1% -38.86%

Cashflow Statement

Concept 2017 Q3 2016 Q4 2016 Q3
OPERATING ACTIVITIES
Net Income -$2.030M -$1.930M $4.020M
YoY Change -150.5% -67.38% -168.74%
Depreciation, Depletion And Amortization $50.00K $60.00K $190.0K
YoY Change -73.68% -40.0% 171.43%
Cash From Operating Activities -$2.020M -$2.440M -$4.640M
YoY Change -56.47% -55.39% 8.92%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$30.00K -$330.0K
YoY Change -96.97% -80.0% 13.79%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $10.78M
YoY Change -100.0% 26850.0%
Cash From Investing Activities -$10.00K -$30.00K $10.45M
YoY Change -100.1% -80.0% -4280.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.966M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.960M 0.000 270.0K
YoY Change 625.93% -190.0%
NET CHANGE
Cash From Operating Activities -2.020M -2.440M -4.640M
Cash From Investing Activities -10.00K -30.00K 10.45M
Cash From Financing Activities 1.960M 0.000 270.0K
Net Change In Cash -70.00K -2.470M 6.080M
YoY Change -101.15% -56.05% -226.4%
FREE CASH FLOW
Cash From Operating Activities -$2.020M -$2.440M -$4.640M
Capital Expenditures -$10.00K -$30.00K -$330.0K
Free Cash Flow -$2.010M -$2.410M -$4.310M
YoY Change -53.36% -54.7% 8.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3461714 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
YIELD10 BIOSCIENCE, INC.
CY2017Q3 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
5.04
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
56000 USD
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
48000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66000 USD
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2702000 USD
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1938000 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
939000 USD
CY2017Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
727000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-84000 USD
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-81000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
339782000 USD
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
342796000 USD
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
544724 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
569225 shares
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1561285 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1208817 shares
CY2016Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29622 sqft
CY2016Q4 us-gaap Assets
Assets
10748000 USD
CY2017Q3 us-gaap Assets
Assets
5572000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
7860000 USD
CY2017Q3 us-gaap Assets Current
AssetsCurrent
3484000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12269000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9782000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7309000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2951000 USD
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
7309000 USD
CY2017Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
2951000 USD
CY2017Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
994084 shares
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1020112 shares
CY2017Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1634636 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28342625 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28402471 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28342625 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28402471 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
28000 USD
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
35000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4021000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5681000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2022000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6841000 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-2.25
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1945000 USD
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
3077000 USD
us-gaap Costs And Expenses
CostsAndExpenses
9473000 USD
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
2205000 USD
us-gaap Costs And Expenses
CostsAndExpenses
7594000 USD
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
622000 USD
CY2017Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0 USD
CY2012 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
38885000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
458000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
158000 USD
CY2016Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
6853000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
3204000 USD
CY2017Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 USD
CY2016Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
2.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
0.70
CY2017Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
0.00
CY2016Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
1259000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
1259000 USD
CY2017Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
CY2016Q3 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
9868000 USD
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1000 USD
CY2017Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 USD
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.44
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.05
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.25
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-9000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
713000 USD
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
203000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-274000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-12000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
9833000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1570000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7617000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2025000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6844000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2612000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8659000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2025000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6844000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.56
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-2.75
CY2017Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.59
CY2016Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
5594000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
122000 USD
CY2017Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1042000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1042000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-40000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
69000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1047000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-828000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-277000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-145000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-1000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-180000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1413000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-715000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-187000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
197000 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-19000 USD
us-gaap Inventory Write Down
InventoryWriteDown
199000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2016Q4 us-gaap Liabilities
Liabilities
4379000 USD
CY2017Q3 us-gaap Liabilities
Liabilities
3023000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10748000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5572000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2758000 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1986000 USD
CY2016Q3 us-gaap Loss On Contract Termination
LossOnContractTermination
2641000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-2487000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-4358000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-274000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1954000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9783000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11987000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6309000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4024000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5672000 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2025000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6844000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-90000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2604000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8655000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1982000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6754000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
591000 USD
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
693000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3000 USD
us-gaap Other Noncash Income Tax Expense
OtherNoncashIncomeTaxExpense
217000 USD
us-gaap Other Noncash Income Tax Expense
OtherNoncashIncomeTaxExpense
0 USD
CY2017Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
317000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
721000 USD
CY2016Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-9000 USD
CY2017Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9000 USD
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4951000 USD
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
363000 USD
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
296000 USD
CY2017Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1966000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1966000 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
10317000 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1739000 USD
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1587000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
111000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
0 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
432000 USD
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
432000 USD
CY2017Q3 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
196000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-333357000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-340201000 USD
CY2016Q3 us-gaap Revenue From Grants
RevenueFromGrants
473000 USD
us-gaap Revenue From Grants
RevenueFromGrants
818000 USD
CY2017Q3 us-gaap Revenue From Grants
RevenueFromGrants
223000 USD
us-gaap Revenue From Grants
RevenueFromGrants
840000 USD
CY2016Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
494000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2272000 USD
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
473000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
818000 USD
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
223000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
840000 USD
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
307000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1530000 USD
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1073000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4215000 USD
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
254000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1155000 USD
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1063000 USD
CY2017Q3 us-gaap Share Price
SharePrice
4.00
us-gaap Stock Issued1
StockIssued1
85000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
CY2016Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27500 shares
CY2017Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27500 shares
CY2017Q2 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
28700000 shares
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Splits
StockIssuedDuringPeriodSharesStockSplits
2900000 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
6369000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
2549000 USD
CY2017Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
10
CY2016Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
121000 USD
CY2017Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
102000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2786900 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2765200 shares
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3410847 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3035352 shares
CY2016Q4 yten Accrued Commercial Manufacturing Current
AccruedCommercialManufacturingCurrent
459000 USD
CY2017Q3 yten Accrued Commercial Manufacturing Current
AccruedCommercialManufacturingCurrent
315000 USD
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
259000 USD
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
68000 USD
CY2016Q3 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1547000 USD
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4522000 USD
CY2017Q3 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1132000 USD
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
3379000 USD
yten Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
655000 USD
yten Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-584000 USD
yten Lease Incentive Paidby Lessor
LeaseIncentivePaidbyLessor
1332000 USD
yten Lease Incentive Paidby Lessor
LeaseIncentivePaidbyLessor
0 USD
CY2016Q4 yten Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
1132000 USD
CY2017Q3 yten Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
1037000 USD
CY2016Q4 yten Liabilities Noncurrent Contract Termination Obligation
LiabilitiesNoncurrentContractTerminationObligation
489000 USD
CY2017Q3 yten Liabilities Noncurrent Contract Termination Obligation
LiabilitiesNoncurrentContractTerminationObligation
0 USD
CY2017Q3 yten Operatingleaseslandlordreimbforleaseimprovementsadditionalpayments
Operatingleaseslandlordreimbforleaseimprovementsadditionalpayments
444000 USD
yten Operatingleaseslandlordreimbursementforleaseimprovements
Operatingleaseslandlordreimbursementforleaseimprovements
889000 USD
yten Period Over Which Capital Resources Are Not Sufficient To Fund Planned Operations
PeriodOverWhichCapitalResourcesAreNotSufficientToFundPlannedOperations
P12M
CY2017Q3 yten Restructuring Contract Termination Fees Payable
RestructuringContractTerminationFeesPayable
728000 USD
yten Restructuring Costs Paid Through Stockand Equipment
RestructuringCostsPaidThroughStockandEquipment
196000 USD
yten Restructuring Costs Paid Through Stockand Equipment
RestructuringCostsPaidThroughStockandEquipment
0 USD
CY2016Q4 yten Restructuring Target Numberof Employees Remaining
RestructuringTargetNumberofEmployeesRemaining
20 employee
CY2016Q3 yten Restructuring Target Numberof Employees Remaining
RestructuringTargetNumberofEmployeesRemaining
20 employee
yten Reversal Of Deferred Financing Costs Related To Purchase Agreement
ReversalOfDeferredFinancingCostsRelatedToPurchaseAgreement
0 USD
yten Reversal Of Deferred Financing Costs Related To Purchase Agreement
ReversalOfDeferredFinancingCostsRelatedToPurchaseAgreement
450000 USD
CY2016 yten Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.06
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company has historically invested its cash equivalents in highly rated money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments, when purchased, are acquired in accordance with the Company&#8217;s investment policy which establishes a concentration limit per issuer. At </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s cash equivalents are invested solely in money market funds.</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides credit to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers&#8217; financial condition and limits the amount of credit extended when deemed necessary.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001121702-17-000084-index-headers.html Edgar Link pending
0001121702-17-000084-index.html Edgar Link pending
0001121702-17-000084.txt Edgar Link pending
0001121702-17-000084-xbrl.zip Edgar Link pending
ex-311x20170930.htm Edgar Link pending
ex-312x20170930.htm Edgar Link pending
ex-321x20170930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yten-20170930.xml Edgar Link completed
yten-20170930.xsd Edgar Link pending
yten-20170930x10q.htm Edgar Link pending
yten-20170930_cal.xml Edgar Link unprocessable
yten-20170930_def.xml Edgar Link unprocessable
yten-20170930_lab.xml Edgar Link unprocessable
yten-20170930_pre.xml Edgar Link unprocessable